Trinity Capital Inc. $TRIN Shares Sold by Quantbot Technologies LP

Quantbot Technologies LP lessened its stake in shares of Trinity Capital Inc. (NASDAQ:TRIN) by 92.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,078 shares of the company’s stock after selling 144,773 shares during the quarter. Quantbot Technologies LP’s holdings in Trinity Capital were worth $171,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Mutual Advisors LLC acquired a new position in Trinity Capital during the third quarter worth $1,421,000. AWM Capital LLC grew its stake in shares of Trinity Capital by 174.2% in the third quarter. AWM Capital LLC now owns 177,090 shares of the company’s stock valued at $2,741,000 after buying an additional 112,507 shares in the last quarter. Beacon Pointe Advisors LLC purchased a new stake in shares of Trinity Capital in the 2nd quarter valued at $737,000. Allworth Financial LP purchased a new stake in shares of Trinity Capital in the 2nd quarter valued at $53,000. Finally, Advisors Asset Management Inc. lifted its stake in Trinity Capital by 40.3% during the 2nd quarter. Advisors Asset Management Inc. now owns 268,699 shares of the company’s stock worth $3,781,000 after acquiring an additional 77,170 shares in the last quarter. 24.62% of the stock is currently owned by institutional investors and hedge funds.

More Trinity Capital News

Here are the key news stories impacting Trinity Capital this week:

• Positive Sentiment: Multiple insider purchases from Chairman Steve Louis Brown and Director Ronald E. Estes — small open-market buys on March 9–11 that increased their holdings (Brown bought 2,103 shares total across filings; Estes bought 605 shares total). Insider accumulation is a commonly bullish signal for investors. SEC filing (Brown) SEC filing (Estes)
• Positive Sentiment: Trinity committed $35 million in growth capital to Neuros Medical to support commercialization of a neuromodulation therapy (Altius system). This adds yield-generating assets to TRIN’s portfolio and supports future fee and interest income. Press release
• Positive Sentiment: Trinity provided $20 million in growth capital to Emboline to commercialize the Emboliner® embolic protection system for TAVR procedures — another MedTech deployment that broadens TRIN’s portfolio exposures and potential interest/fee income. Press release
• Neutral Sentiment: Coverage pick-up on the Neuros Medical deal from MonitorDaily restates the $35M commitment; useful for visibility but unlikely to move fundamentals beyond the original PR. Article
• Negative Sentiment: Seeking Alpha flagged a rating downgrade on TRINZ (7.875% Notes due 2029) and notes the notes are likely to be called after March 2026 as Trinity pursues cheaper secured refinancing. While the firm shows stable credit quality and contained NPLs, refinancing and a rating cut create near-term funding and perception risks that can pressure the stock and cost of capital. Article

Analyst Ratings Changes

TRIN has been the subject of a number of research analyst reports. Clear Str upgraded Trinity Capital to a “strong-buy” rating in a report on Wednesday, February 4th. Noble Financial began coverage on shares of Trinity Capital in a research report on Thursday, December 11th. They set a “buy” rating on the stock. Loop Capital set a $17.00 price objective on shares of Trinity Capital in a research note on Thursday, December 11th. Citigroup restated an “outperform” rating on shares of Trinity Capital in a report on Tuesday, January 27th. Finally, Capital One Financial set a $17.00 target price on shares of Trinity Capital in a research note on Thursday, December 11th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $16.29.

Insider Activity at Trinity Capital

In other news, CEO Kyle Steven Brown bought 3,333 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was purchased at an average price of $14.90 per share, for a total transaction of $49,661.70. Following the completion of the purchase, the chief executive officer owned 376,775 shares in the company, valued at approximately $5,613,947.50. This trade represents a 0.89% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have acquired a total of 7,741 shares of company stock worth $115,358 in the last three months. Insiders own 5.31% of the company’s stock.

Trinity Capital Stock Performance

TRIN stock opened at $14.80 on Thursday. The company’s 50 day moving average price is $15.71 and its 200 day moving average price is $15.41. The firm has a market capitalization of $1.23 billion, a price-to-earnings ratio of 7.55 and a beta of 0.55. Trinity Capital Inc. has a fifty-two week low of $12.50 and a fifty-two week high of $17.20.

Trinity Capital (NASDAQ:TRIN) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.01. Trinity Capital had a net margin of 46.18% and a return on equity of 14.97%. The company had revenue of $58.89 million during the quarter, compared to the consensus estimate of $79.83 million. Equities analysts forecast that Trinity Capital Inc. will post 2.06 EPS for the current fiscal year.

Trinity Capital Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be given a dividend of $0.17 per share. This represents a c) annualized dividend and a dividend yield of 13.8%. The ex-dividend date of this dividend is Friday, March 13th. Trinity Capital’s payout ratio is 104.08%.

Trinity Capital Profile

Trinity Capital Corporation (NASDAQ: TRIN) is a publicly traded business development company that provides flexible financing solutions to venture-backed and growth-stage companies. As a venture lender, Trinity Capital offers customized capital structures, including secured debt and equity co-investment, designed to support companies that have progressed beyond early-stage funding but still require non-dilutive growth capital.

The company focuses its investments on technology-driven sectors such as software, fintech, healthcare, life sciences and cleantech.